Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Diabetes Drugs’ Pancreas Risk Not Backed by Evidence: EMA
Diabetes Drugs’ Pancreas Risk Not Backed by Evidence: EMA
Diabetes Drugs’ Pancreas Risk Not Backed by Evidence: EMA
Submitted by
admin
on July 26, 2013 - 9:03am
Source:
Bloomberg
News Tags:
diabetes
Europe
Byetta
Bristol-Myers Squibb
Merck
Januvia
GLP-1 agonist
Novo Nordisk
Victoza
Headline:
Diabetes Drugs’ Pancreas Risk Not Backed by Evidence: EMA
Do Not Allow Advertisers to Use My Personal information
